The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
Summary
- Eligibility
- for people ages up to 30 years (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Amit Sabnis
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Amit Sabnis
Assistant Professor, Pediatrics, School of Medicine. Authored (or co-authored) 30 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Dana-Farber Cancer Institute
- ID
- NCT02520713
- Study Type
- Observational
- Participants
- Expecting 825 study participants
- Last Updated